申请人:Ben Gurion University Of The Negev Research And
Development Authority
公开号:EP2826472A2
公开(公告)日:2015-01-21
The present invention is directed to use of a series of compounds represented by the structure of formula I and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto:
本发明涉及以式 I 结构为代表的一系列化合物和包含这些化合物的组合物,用于激活端粒酶和治疗与之相关的疾病、失调和/或病症:
TRI-ARYL COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME
申请人:Ben-gurion University Of The Negev
Research And Development Authority
公开号:EP2152663A2
公开(公告)日:2010-02-17
TELOMERASE ACTIVATING COMPOUNDS AND METHODS OF USE THEREOF
申请人:Gazit Aviv
公开号:US20100267667A1
公开(公告)日:2010-10-21
The present invention is directed to use of a series of compounds and compositions comprising the same for activating telomerase and treating diseases, disorders and/or conditions related thereto.